SAGAN PAUL has filed 5 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 5876 shares of Okta, Inc. ($OKTA) on December 19, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Okta, Inc. | $OKTA | SAGAN PAUL | Director | A | Restricted Stock Units | 5876 | $0.00 | 5,876.0000 | 179,393,000 | 9999.99% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | SAGAN PAUL | Director | A | Stock Option (Right to Buy) | 25512 | $0.00 | 25,512.0000 | 384,000,000 | 9999.99% | 0.01% |
| March 3, 2025 | Moderna, Inc. | $MRNA | SAGAN PAUL | Director | P | Common Stock | 31620 | $31.76 | 494,133.0000 | 384,000,000 | 6.84% | 0.01% |
| May 6, 2024 | Moderna, Inc. | $MRNA | SAGAN PAUL | Director | A | Stock Option (Right to Buy) | 7557 | $0.00 | 7,557.0000 | 382,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Moderna, Inc. | $MRNA | SAGAN PAUL | Director | A | Stock Option (Right to Buy) | 6134 | $0.00 | 6,134.0000 | 416,000,000 | 9999.99% | 0.00% |